Ma Liuxue, Wang Huijuan, Li Xin, Dai Zixin, Zhang Jianwei, Gao Jinxia
Liangzhou Hospital, Wuwei, China.
Gansu Cancer Hospital, Lanzhou, China.
Medicine (Baltimore). 2025 Aug 29;104(35):e43992. doi: 10.1097/MD.0000000000043992.
High-grade myofibroblastic sarcoma (HGMS) is a rare mesenchymal tumor with a high recurrence and metastatic rate. Few cases of high-grade myofibroblastic sarcomas have been reported. Herein, we report the first case of HGMS originating from the thyroid.
Based on the findings of thyroid, pathological examination, and immunohistochemical staining, grade III myofibroblastic sarcoma (MS) was diagnosed. Meanwhile, systemic imaging revealed multiple metastases in the scalp, lung, bone, liver, spleen, pancreas.
The patient had not received any treatment and expired 28 days after admission.
HGMS of thyroid shows high invasiveness and metastatic potential, often leading to rapid disease progression and poor survival outcomes. Early diagnosis and intervention guided by clinical evaluation, pathological findings, and imaging are essential to improve patient prognosis.
高级别肌成纤维细胞肉瘤(HGMS)是一种罕见的间叶性肿瘤,具有高复发率和转移率。高级别肌成纤维细胞肉瘤的病例报道较少。在此,我们报告首例起源于甲状腺的HGMS。
根据甲状腺检查结果、病理检查及免疫组化染色,诊断为III级肌成纤维细胞肉瘤(MS)。同时,全身影像学检查显示头皮、肺、骨、肝、脾、胰腺有多处转移。
患者未接受任何治疗,入院28天后死亡。
甲状腺HGMS具有高侵袭性和转移潜能,常导致疾病快速进展和生存预后不良。以临床评估、病理结果和影像学检查为指导的早期诊断和干预对于改善患者预后至关重要。